Skip to main content
. 2012 Jan 6;14(4):445–450. doi: 10.1093/icvts/ivr142

Table 1:

Hybrid procedures: preoperative data (n = 54)

Monopolar (n = 19) Bipolar (n = 35) P-value
Age 61.2 ± 8.6 57.1 ± 9.5 0.073
M/F 16/3 (84.2/15.8) 24/11 (68.5/31.4) 0.23
BMI 27.6 ± 4.6 26.8 ± 3.6 0.84
Diabetes 0 (0) 1 (2.8) 0.71
Hypertension 7 (36.8) 15 (42.8) 0.55
TIA/CVA 1 (5.3) 0 (0) 0.28
Type of preoperative AF
 Paroxysmal 5 (26.3) 16 (45.7) 0.054
 Persistent 4 (21.1) 8 (22.8)
 Long-standing persistent 10 (52.6) 11 (31.5)
Prevalence of AF (68% CI)
 Paroxysmal 20.0 [16.8–23.3] 22.3 [19.2–257] 0.74
 Persistent 34.7 [31.2–38.9] 32.6 [29.1–36.9]
  Long-standing persistent 63.6 [59.9–67.1] 61.3 [57.4–65.0]
EHRA Score 4 [3–4] 4 [3–4] >0.9
Duration of preoperative AF (years) 5 [3–8.5] 5 [4.2–9.0] 0.66
Anti-arrhythmic drugs
 Amiodaron 2 (10.5) 7 (20.0) 0.08
 Dysopiramide 1 (5.3) 2 (5.7)
 Flecainide 6 (31.5) 15 (42.8)
 Propaphenon 1 (5.3) 2 (5.7)
 Sotalol 5 (26.3) 11 (31.4)
Electrical cardioversion 15 (78.9) 17 (48.5) 0.06
Previous catheter ablation
 For AF 6 (31.5) 12 (34.3) 0.65
 For atrial flutter 5 (26.3) 9 (25.7)
 Preoperative pace maker 2 (10.5) 2 (5.3) 0.88
Anticoagulant status
 Sodium Warfarin 16 (84.2) 30 (85.7) 0.76
 Aspirin 5 (26.3) 10 (28.5)
LAVI (ml/m2) 47 ± 11 50 ± 12 0.08
LAMax (ml/m2) 49 ± 20 52 ± 25 0.63
LAMin (ml/m2) 30 ± 15 32 ± 18 0.90
LAEF (%) 38 ± 12 38 ± 11 0.90
LA A-P (cm) 5.0 ± 0.5 5.2 ± 0.5 0.77
LA S-I (cm) 6.4 ± 0.5 6.3 ± 0.7 0.60

Normal data were presented as mean ± 1 standard deviation (SD), non-parametric data as median and [interquartile range] and discrete data as percentages (%).

M/F: male/female; BMI: body mass index; AF: atrial fibrillation; CI: confidence interval; EHRA: European Heart Rhythm Association; LAVI: (biplane) left atrial volume index; LAMax: maximum left atrial volume; LAMin: minimum left atrial volume; LAEF: left atrial emptying fraction; LA A-P: left atrial antero-posterior diameter; LA S-I: left atrial antero-posterior diameter.